Clinical Trial Update: 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects [Phase 3]

View source ↗

Summary

A Phase 3 safety, tolerability, and pharmacokinetics study of TOPROL-XL in hypertensive pediatric subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• TOPROL XL (METOPROLOL SUCCINATE)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Phase 3 | Status: COMPLETED